Showing results (101-110 of 207) with videos related to

Sort By:
Pageof 21
Antimicrobial Agents and Chemotherapy|December 14, 2011
Frequentist and Bayesian pharmacometric-based approaches to facilitate critically needed new antibiotic development: overcoming lies, damn lies, and statisticsPaul G Ambrose, Jeffrey P Hammel, Sujata M Bhavnani, et al.
Leukemia Research|January 1, 1988
Aplastic anaemia incidence in parts of the United Kingdom in 1985R A Cartwright, P A McKinney, L Williams, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2013
Clinical pharmacodynamic index identification for micafungin in esophageal candidiasis: dosing strategy optimizationDavid R Andes, Daniel K Reynolds, Scott A Van Wart, et al.
Clinical and Experimental Immunology|August 1, 1994
Serum soluble CD23 in patients with hypogammaglobulinaemiaA S Bansal, M R Haeney, S Cochrane, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2023
Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil HydrobromideH Ganesan, V K Gupta, M C Safir, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2009
Impact of different factors on the probability of clinical response in tigecycline-treated patients with intra-abdominal infectionsS M Bhavnani, C M Rubino, P G Ambrose, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2018
Norepinephrine in Combination with Antibiotic Therapy Increases both the Bacterial Replication Rate and Bactericidal ActivityPaul G Ambrose, Brian D VanScoy, John Adams, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
Evaluation of the pharmacokinetics and pharmacodynamics of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infections using data from two phase 2 clinical studiesOlanrewaju O Okusanya, Sujata M Bhavnani, Jeffrey P Hammel, et al.
Infection and Immunity|November 17, 2010
MyD88 deficiency leads to decreased NK cell gamma interferon production and T cell recruitment during Chlamydia muridarum genital tract infection, but a predominant Th1 response and enhanced monocytic inflammation are associated with infection resolutionUma M Nagarajan, James Sikes, Daniel Prantner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
Application of pharmacokinetic-pharmacodynamic modeling and the justification of a novel fusidic acid dosing regimen: raising Lazarus from the deadBrian T Tsuji, Olanrewaju O Okusanya, Jurgen B Bulitta, et al.
Pageof 21